Fimmu-09-02948-g002.jpg
Size of this preview:
800 × 389 pixels
.
Other resolutions:
320 × 156 pixels
|
640 × 311 pixels
|
1,084 × 527 pixels
.
Summary
Description Fimmu-09-02948-g002.jpg |
English:
Figure 2. Murine monocyte and liver macrophage subsets and targeted therapeutic strategies. (A) In mice, (left) blood and liver-infiltrating monocytes differentially express the markers Ly6C, CCR2, and CX3CR1. During steady-state, the liver macrophage pool can be expanded due to recruitment of circulating (CCR2+) Ly6Chigh monocytes, a process markedly increased after injury. Following their infiltration, monocytes undergo a maturation process into (middle) (CX3CR1+) Ly6Clow monocyte-derived macrophages (MoMFs) that exhibit a CD11bhigh F4/80+ profile. In contrast, the (right) embryonically derived (CX3CR1−) liver-resident Kupffer cells (KCs) are CD11b+ F4/80high cells expressing the prototypical markers Clec4F and Tim4. Markers designated in bold are currently used to distinguish these two subsets. (B) The table summarizes therapeutic interventions targeting monocyte recruitment, macrophage polarization/differentiation or KC activation in experimental models of acute liver injury.
|
Date | |
Source | https://www.frontiersin.org/articles/10.3389/fimmu.2018.02948/full |
Author | Evangelos Triantafyllou, Kevin J. Woollard, Mark J. W. McPhail, Charalambos G. Antoniades and Lucia A. Possamai |
Licensing
This file is licensed under the
Creative Commons
Attribution 4.0 International
license.
-
You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
-
Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.